In quality health care accountability and protection, further providing for definitions and providing for utilization management for stage four, advanced metastatic cancer drugs; and making a repeal.

An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in quality health care accountability and protection, further providing for definitions and providing for utilization management for stage four, advanced metastatic cancer drugs; and making a repeal.

Source: OpenStates · fetched April 21, 2026

• Medicaid / public insuranceindirectModerate impactMedium certainty

  This bill may affect Medicaid beneficiaries by potentially increasing the cost of certain cancer drugs, which could lead to changes in coverage or prior authorization requirements for these treatments.

  “utilization management for stage four, advanced metastatic cancer drugs”· Quality health care accountability and protection

• Low-income / working-classindirectModerate impactMedium certainty

  Low-income individuals, particularly those with advanced metastatic cancer, may face increased financial burdens or access challenges if the utilization management of cancer drugs leads to higher out-of-pocket costs or restricted access to necessary treatments.

  “utilization management for stage four, advanced metastatic cancer drugs”· Quality health care accountability and protection

• Reproductive-age personindirectMinor impactLow certainty

  While not explicitly stated, changes in utilization management for advanced cancer drugs could indirectly impact individuals of reproductive age undergoing cancer treatment, potentially affecting their treatment options and associated costs.

  “utilization management for stage four, advanced metastatic cancer drugs”· Quality health care accountability and protection